Target intelligence / Profile preview

T-cell receptor recognizing Poa compressa-derived peptide–MHC complexes (TCR)

Target
TCR
Molecular classification
Receptor, T-cell receptor complex
01

Overview

The T-cell receptor (TCR) recognizing Poa compressa-derived peptide–MHC complexes is a membrane-bound protein complex on CD4+ T cells that plays a pivotal role in the allergic response to Canada bluegrass pollen [1]. This TCR specifically identifies allergenic peptides, such as those from the major allergens Poa c 1 and Poa c 5, when they are presented by Major Histocompatibility Complex (MHC) class II molecules on antigen-presenting cells [1, 2]. The binding of the TCR to these complexes initiates a signaling cascade that drives the differentiation and activation of Th2 cells [3]. These cells then secrete cytokines like IL-4 and IL-13, which stimulate B cells to produce allergen-specific IgE, ultimately leading to the mast cell degranulation and eosinophilic inflammation seen in allergic rhinitis and asthma [3, 4]. In a therapeutic context, this TCR-peptide-MHC interaction is the primary target of allergen-specific immunotherapy (AIT) [4]. AIT involves the controlled, repeated administration of grass pollen extracts to modify the immune system's response to the allergen [4, 5]. By targeting the TCR signaling pathway under specific conditions, AIT induces peripheral T-cell tolerance, characterized by the expansion of regulatory T cells (Tregs) and a shift from a Th2-dominated response to a Th1 or Treg-dominated one [4, 5]. This modulation results in long-term clinical desensitization and a reduction in the inflammatory symptoms associated with grass pollen exposure [5]. Citations: [1] WHO/IUIS Allergen Nomenclature Database (allergen.org); [2] UniProt Consortium, "T-cell receptor"; [3] Janeway's Immunobiology, 9th Edition; [4] Akdis, C. A., & Akdis, M. (2014), "Mechanisms of allergen-specific immunotherapy," J Allergy Clin Immunol; [5] Durham, S. R., & Shamji, M. H. (2023), "Allergen immunotherapy: past, present and future," Nature Reviews Immunology.

Other names
Canada bluegrass allergen-specific T-cell receptorPoa c-specific T-cell receptorT-cell receptor recognizing Canada bluegrass allergensPoa compressa-specific TCR
02

Mechanism of action

Induction of immune tolerance through allergen-specific immunotherapy (AIT), leading to Th2 cell desensitization and regulatory T cell (Treg) expansion.

03

Biological functions

Immune responseAntigen recognitionT-cell activationSignal transduction
04

Disease associations

Allergic rhinitisAsthmaAllergyType I hypersensitivity
05

Safety considerations

AnaphylaxisSystemic allergic reactionsLocal site reactions (e.g., oral pruritus, injection site swelling)
06

Interacting drugs

Grass pollen allergen extract

2 more in the full profile.

07

Biomarkers

Allergen-specific IgEAllergen-specific IgG4T-cell activation markers (e.g., CD154, CD137)Cytokine levels (IL-4, IL-5, IL-10, TGF-beta)

Beyond the preview

Go deeper on T-cell receptor recognizing Poa compressa-derived peptide–MHC complexes (TCR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on T-cell receptor recognizing Poa compressa-derived peptide–MHC complexes (TCR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call